A rare presentation of coeliac crisis in a patient with Neurogenin‐3 mutation congenital enteropathy
Neurogenin‐3 (NEUROG3 ) mutations have been associated with congenital enteropathy, anendocrinosis, and early‐onset diabetes and patients often require parenteral nutrition (PN). We present a case of homozygous NEUROG3 mutation who, having established enteral autonomy by 2.5 years old, re‐presented with acute intestinal failure (IF) characterised by high stool output and metabolic acidosis. Investigations revealed positive coeliac serology, with duodenal histology confirming coeliac disease as the cause for relapsed IF. Institution of a gluten‐free diet led to clinical recovery and PN cessation, although serological and histological markers of coeliac disease were slow to improve. Subsequently, the patient developed autoimmune thyroid disease. This case expands the recognised phenotype of NEUROG3 ‐related disease, highlighting the importance of considering alternative causes for relapsed IF. Persistently elevated coeliac serology despite gluten‐free diet, alongside development of autoimmune thyroid disease, suggest the possibility of broader immune dysregulation or autoimmune association with atypical phenotype in NEUROG3 mutation.
Authors
- Kathleen H. McGrath (ORCID: https://orcid.org/0000-0003-0016-6441)
- Timothy C. Lai (ORCID: https://orcid.org/0000-0003-4659-4433)
- Colleen E. D’Arcy (ORCID: https://orcid.org/0000-0002-6483-3226)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Monash Children’s Hospital (AU)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- JPGN Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/jpr3.70285
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- General Motors Corporation
- Monash University